Analyst consensus rating

Tenaya Therapeutics Analyst Rating: none

Direct answer

Tenaya Therapeutics's consensus rating is none.

6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.67.
Forecast evidence checked November 21, 2026.

Get free Tenaya Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$0.29
Average price target
$3.67
High price target
$6.00
Low price target
$2.00
Low target gap
+597.8%
Target upside
+1,179.4%
High target gap
+1,993.5%
Target range width
1,395.7%
Consensus rating
none
Analysts
6
Evidence date
November 21, 2026
Valid through
November 28, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Tenaya Therapeutics?

Tenaya Therapeutics has a verified none consensus. The same dataset has an average price target of $3.67.

How far are Tenaya Therapeutics's low and high targets from the recorded price?

The low target implies +597.8%, while the high target implies +1,993.5%.

How many analysts are included in Tenaya Therapeutics's consensus?

The verified consensus includes 6 analysts.

How is Tenaya Therapeutics's target upside or downside calculated?

The average target of $3.67 is divided by the recorded price of $0.29, then one is subtracted to produce +1,179.4%. This does not guarantee a future return.

When was Tenaya Therapeutics's analyst forecast verified?

The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.